Medico Remedies Ltd
NSE:MEDICO
Medico Remedies Ltd
NSE:MEDICO
Price:
40.79
INR
-1.19%
Market Closed
Market Cap:
₹3.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Medico Remedies Ltd
NSE:MEDICO
|
IN |
|
Rocky Brands Inc
NASDAQ:RCKY
|
US |
|
E2open Parent Holdings Inc
NYSE:ETWO
|
US |
|
Jiangsu DongHua Testing Technology Co Ltd
SZSE:300354
|
CN |
|
Hiecise Precision Equipment Co Ltd
SZSE:300809
|
CN |
Income Statement
Earnings Waterfall
Medico Remedies Ltd
Medico Remedies Ltd
Income Statement
Medico Remedies Ltd
Medico Remedies Ltd
Currency: INR
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
1 210
N/A
|
1 542
+27%
|
1 360
-12%
|
1 749
+29%
|
1 404
-20%
|
1 388
-1%
|
1 407
+1%
|
1 316
-6%
|
1 449
+10%
|
1 442
0%
|
1 412
-2%
|
1 510
+7%
|
1 509
0%
|
1 584
+5%
|
1 717
+8%
|
1 909
+11%
|
|
| Gross Profit | |||||||||||||||||
| Cost of Revenue |
(873)
|
(1 136)
|
(998)
|
(1 281)
|
(1 049)
|
(1 024)
|
(1 066)
|
(998)
|
(1 099)
|
(1 081)
|
(1 043)
|
(1 114)
|
(1 191)
|
(1 136)
|
(1 238)
|
(1 393)
|
|
| Gross Profit |
337
N/A
|
405
+20%
|
362
-11%
|
468
+29%
|
356
-24%
|
364
+2%
|
341
-6%
|
318
-7%
|
350
+10%
|
362
+3%
|
370
+2%
|
396
+7%
|
319
-20%
|
448
+41%
|
479
+7%
|
516
+8%
|
|
| Operating Income | |||||||||||||||||
| Operating Expenses |
(286)
|
(362)
|
(313)
|
(392)
|
(287)
|
(270)
|
(248)
|
(231)
|
(250)
|
(257)
|
(272)
|
(295)
|
(199)
|
(328)
|
(356)
|
(381)
|
|
| Selling, General & Administrative |
(56)
|
(68)
|
(57)
|
(74)
|
(58)
|
(57)
|
(58)
|
(58)
|
(59)
|
(60)
|
(59)
|
(61)
|
(169)
|
(65)
|
(70)
|
(72)
|
|
| Depreciation & Amortization |
(21)
|
(27)
|
(24)
|
(32)
|
(27)
|
(28)
|
(29)
|
(29)
|
(29)
|
(29)
|
(30)
|
(30)
|
(30)
|
(30)
|
(30)
|
(31)
|
|
| Other Operating Expenses |
(209)
|
(267)
|
(231)
|
(286)
|
(202)
|
(184)
|
(161)
|
(144)
|
(162)
|
(169)
|
(185)
|
(205)
|
0
|
(232)
|
(256)
|
(279)
|
|
| Operating Income |
51
N/A
|
44
-15%
|
50
+14%
|
76
+53%
|
69
-9%
|
94
+36%
|
93
-1%
|
87
-7%
|
100
+16%
|
104
+4%
|
97
-7%
|
100
+3%
|
120
+20%
|
120
0%
|
123
+3%
|
135
+10%
|
|
| Pre-Tax Income | |||||||||||||||||
| Interest Income Expense |
19
|
(8)
|
(6)
|
(8)
|
37
|
(8)
|
(8)
|
(8)
|
18
|
(8)
|
(9)
|
(9)
|
24
|
(13)
|
(13)
|
(14)
|
|
| Total Other Income |
(5)
|
36
|
41
|
50
|
(5)
|
27
|
21
|
15
|
(5)
|
21
|
18
|
30
|
(9)
|
31
|
41
|
34
|
|
| Pre-Tax Income |
66
N/A
|
72
+10%
|
85
+17%
|
118
+39%
|
101
-14%
|
113
+12%
|
106
-6%
|
94
-12%
|
113
+21%
|
116
+2%
|
106
-9%
|
120
+14%
|
135
+12%
|
138
+2%
|
151
+10%
|
154
+2%
|
|
| Net Income | |||||||||||||||||
| Tax Provision |
(17)
|
(20)
|
(22)
|
(32)
|
(29)
|
(31)
|
(29)
|
(24)
|
(30)
|
(30)
|
(29)
|
(32)
|
(34)
|
(34)
|
(38)
|
(38)
|
|
| Income from Continuing Operations |
49
|
52
|
63
|
85
|
72
|
82
|
78
|
70
|
83
|
86
|
77
|
89
|
101
|
103
|
113
|
116
|
|
| Net Income (Common) |
49
N/A
|
52
+7%
|
63
+20%
|
85
+36%
|
72
-15%
|
82
+13%
|
78
-5%
|
70
-10%
|
83
+19%
|
86
+3%
|
77
-10%
|
89
+15%
|
101
+14%
|
103
+2%
|
113
+10%
|
116
+2%
|
|
| EPS (Diluted) |
0.59
N/A
|
3.22
+446%
|
0.75
-77%
|
1.03
+37%
|
0.87
-16%
|
0.99
+14%
|
0.93
-6%
|
0.83
-11%
|
1
+20%
|
1.02
+2%
|
0.94
-8%
|
1.07
+14%
|
1.22
+14%
|
1.26
+3%
|
1.38
+10%
|
1.41
+2%
|
|
Switch to:
Switch to:
See Also
Discover More
